OMGene

OMGeneOMGene
OMGene

OMGene

OMGene is a biotechnology company focused on developing gene therapies for rare genetic diseases.

Website
DR 162017Active14Boston, United States
Rate
Advertise here

About

OMGene is a technology-driven biopharmaceutical company focused on developing and manufacturing complex generic APIs, including peptides, semi-synthetics, synthetic molecules, and oligonucleotides. They also engage in formulation development for injectables and oral peptide delivery. Omgene aims to provide affordable, high-quality healthcare solutions for therapeutic areas such as anti-cancer, anti-diabetic, infertility, and obesity.
Frequently asked

What does OMGene do?

OMGene is a technology-driven biopharmaceutical company focused on developing and manufacturing complex generic APIs, including peptides, semi-synthetics, synthetic molecules, and oligonucleotides. They also engage in formulation development for injectables and oral peptide delivery. Omgene aims to provide affordable, high-quality healthcare solutions for therapeutic areas such as anti-cancer, anti-diabetic, infertility, and obesity.

What is OMGene's revenue?

StartupHub estimates OMGene's annual revenue at $2.9M (range $1.7M to $7.0M, 65% confidence), based on comparable companies in the sector.

Where is OMGene headquartered?

OMGene is headquartered in Boston, United States.

When was OMGene founded?

OMGene was founded in 2017.

What industry does OMGene operate in?

OMGene operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Gene Therapy.

How many employees does OMGene have?

OMGene has approximately 14 people on record.

HEADCOUNT
14
DOMAIN RATING
16
Comments

No comments yet. Be the first to share your take.